$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What is the market price of Pitobrutinib/Pitobrutinib after it is launched in China?
2026-02-01 22:25:32
Check Details
Latest prices for talazoparib tosylate in 2025
2026-02-01 22:25:32
Check Details
Circumstances in which the use of crizotinib/Xalkori is not clinically recommended
2026-02-01 22:25:32
Check Details
Zongertinib-Hernexeos drug introduction, indications and analysis of the latest marketing trends
2026-02-01 22:25:32
Check Details
Which drug is better and more effective than serputinib/serpatinib vs platinib?
2026-02-01 22:25:32
Check Details
Is Enasidenib suitable for long-term use in young patients?
2026-02-01 22:25:32
Check Details
Can patients with thrombocytopenia be cured by taking avatrombopag/sucosin?
2026-02-01 22:25:32
Check Details
Dordaviprone-Modeyso instruction manual Chinese introduction
2026-02-01 22:25:32
Check Details
Risks of discontinuation of Bituvi/Bikonprenol Tablets blockers midway
2026-02-01 22:25:32
Check Details
Once I start taking Deuterocolexitinib/Sondido, can I stop taking it?
2026-02-01 22:25:32
Check Details
Detailed explanation of four groups of people who should not take Apremilast tablets
2026-02-01 22:25:32
Check Details
Which country is Valganciclovir/Vasavi produced in?
2026-02-01 22:25:32
Check Details
1
2
...
1906
1907
1908
1909
1910
1911
1912
...
10227
10228
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
2
Valganciclovir (Valcyte) in Post-Transplant CMV Management: A Comprehensive Guide
3
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
4
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
5
Resmetirom Indication Clarification: Approved for NASH Fibrosis, Not Hepatitis B Cirrhosis
6
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
7
Anagrelide vs. Hydroxyurea in Essential Thrombocythemia: Efficacy Profiles and Clinical Positioning
8
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
9
Sabril (Vigabatrin) Explained: Indications, Vision Loss Risk & Key Warnings
10
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
11
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
12
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials